xylazine

Xylazine placed on the Schedule III list in Delaware

Sam HautGovernment, Headlines

The Delaware Secretary of State Jeff Bullock issued an emergency order on Friday placing the non-opioid drug xylazine used mostly in veterinarian medicine, on the list of Schedule III drugs. Bullock made the decision after the Delaware Controlled Substance Advisory Committee recommended it May 5, 2023. Bullock said in a press release about the decision that xylazine has a dangerous …

Pharma

Walgreens, CVS to pay Delaware $43.6M opioid settlement

Charlie MegginsonGovernment, Headlines

Delaware stands to receive some $43.6 million from settlements with CVS and Walgreens over their roles in America’s opioid epidemic. In total, CVS will pay $5 billion and Walgreens will pay $5.7 billion, which will be distributed amongst states and municipalities involved in the litigation. The announcement comes just days after public health officials announced that Nov. 2022 was Delaware’s …

drugs 1 1524998

Purdue Pharma agrees to new opioid settlement after Delaware, other states appeal

Charlie MegginsonGovernment, Headlines, Health

Purdue Pharma and the Sackler family could pay up to $6 billion for the OxyContin maker’s role in the deadly opioid epidemic, Attorney General Kathy Jennings announced Thursday. If approved, Delaware would receive nearly $50 million under the terms of the tentative settlement that includes almost all U.S. states and thousands of local governments. Jennings and eight other attorneys general …

Del. health department marks 100,000 substance abuse treatment referrals

Charlie MegginsonHeadlines, Health

Katy L. Pack/Getty Images The Delaware Department of Health and Social Services has surpassed a milestone of 100,000 Delawareans to substance use and mental health services. Referrals are made through the Delaware Treatment and Referral Network, conducted by the agency’s Division of Substance Use and Mental Health. Delaware is the first state to make more than 100,000 referrals using the …